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P heochromocytomas arising from chromaffin cells in the adrenal medulla and paraganglia secretes 
catecholamines that result in widespread sympathetic 
derangement of homeostasis.  Clinical symptoms due to 
the tumor’s overproduction of catecholamines include 
tachycardia,  high blood pressure,  sweating and head-
ache.  The standard treatment for pheochromocytoma is 
surgical resection.  During surgery and the periopera-
tive period,  blood pressure fluctuates significantly due 
to changes in plasma levels of catecholamines secreted 
by the tumor.  Thus,  the management of blood pressure 
in adrenalectomy for pheochromocytoma becomes a 
significant concern for surgeons and anesthesiologists.  
The fluctuation has 2 parts.  Just before the drainage 
veins are clamped,  blood pressure rises due to tumor 
manipulation and the resultant catecholamine surge;  
then,  after clamping,  the blood pressure drops precipi-
tously.  In some patients,  hypotension persists even 
postoperatively,  and intensive care may be required.  
However,  the fluctuation in blood pressure varies from 
patient to patient,  and not all cases show large fluctua-
tions.  If we can determine beforehand which patients 
will likely have persistent postoperative hypotension,  
perioperative management could be made more safe 
and predictable.  Several studies have reported predic-
tors of postoperative hypotension,  but there is no con-
sensus on related factors [1-4].  To identify the predic-
tors of postoperative hypotension,  we reviewed our 
series of adrenalectomy for pheochromocytoma.
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The management of blood pressure is a significant concern for surgeons and anesthesiologists performing adre-
nalectomy for pheochromocytoma.  We evaluated clinical factors in pheochromocytoma patients to identify the 
predictors of postoperative hypotension.  The medical records of patients who underwent adrenalectomy for 
pheochromocytoma between 2001 and 2017 were retrospectively reviewed and clinical and biochemical data 
were evaluated.  Of 29 patients,  13 patients needed catecholamine support in the perisurgical period while 16 
patients did not.  There were significant differences in median age,  tumor size,  and blood pressure drop (max-
min) between the 2 groups (68 vs 53 years old,  p= 0.045; 50 vs 32 mm diameter,  p= 0.022; 110 vs 71 mmHg,  
p= 0.015 respectively).  In univariate logistic analysis,  age > 65.5 years,  tumor size > 34.5 mm,  urine metaneph-
rine > 0.205 mg/day and urine normetanephrine > 0.665 mg/day were significant predictors of prolonged hypo-
tension requiring postoperative catecholamine support.  Tumor size and urine metanephrine and urine norme-
tanephrine levels were correlated with postoperative hypotension.  These predictors may help in the safe 
perioperative management of pheochromocytoma patients treated with adrenalectomy.
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Materials and Methods
We reviewed the medical records of all patients who 
underwent adrenalectomy at Ehime University Hospital 
and were pathologically diagnosed as having pheochro-
mocytoma between 2001 and 2017.  All adrenalectomy 
cases were pheochromocytomas; there were no para-
gangliomas.  Preoperative capacity loading with saline 
was performed in all cases and circulating blood volume 
was maintained.  In order to increase circulating blood 
volume,  a 500-1,000 mL saline drip was started from 
3 h prior to operation in all patients.  Use of doxazosin 
was determined by an endocrinologist.  Postoperative 
hypotension was defined as the necessity of catechol-
amine supplementation to maintain systolic blood pres-
sure (SBP) 90 mmHg at any time during hospital recov-
ery.  Blood pressure fluctuation is especially large at the 
time of clamping the drainage veins.  We used SBP as 
the blood pressure and defined blood pressure fluctua-
tion as the difference between the maximum blood 
pressure prior to vein clamping and the minimum 
blood pressure after clamping.  Patients were divided 
into 2 groups: Group 1,  who needed catecholamine 
support postoperatively and Group 2,  who did not need 
catecholamine at all.  Patients’ background,  surgical 
outcomes,  and biochemical data were compared 
between the 2 groups.  The statistical difference between 
the two groups was examined by the Mann-Whitney U 
test.  Next,  we found appropriate cutoff points for con-
tinuous variables.  We selected these cutoffs by identify-
ing predictor variable values on receiver operating 
characteristic curves.  The value with the maximum 
sensitivity and minimal loss of specificity was chosen.  
Finally,  we selected candidate variables with p-values 
< 0.05 based on univariate analyses.
For all statistics,  IBM SPSS Statistics Version 21 
(IBM,  Armonk,  NY,  USA) was used.  This study was 
approved by the institutional review board of Ehime 
University (IRB number 1905012).
Results
We evaluated 29 patients who underwent adrenalec-
tomy for pheochromocytoma.  Thirteen patients were 
assigned to Group 1 and 16 to Group 2.  The back-
ground of all patients,  surgical outcomes,  and the 
comparison of clinical and biochemical factors between 
the 2 groups are shown in Table 1.  The surgical 
approach differed based on the case.  Three patients 
who were started with laparoscopic surgery were con-
verted to laparotomy during the surgery.  The reason for 
open conversion was bleeding in 2 cases and omentum 
adhesion in 1 case.  Most of the patients in group 1 had 
a small amount of blood loss.  Only one patient had 
bleeding from renal vein,  and the amount of intraoper-
ative blood loss was 2,190 mL.  There were significant 
differences in tumor size and blood pressure fluctuation 
between the 2 groups (68 vs 53 years old,  p = 0.045; 50 
vs 32 mm diameter,  p = 0.022; 110 vs 71 mmHg,  
p = 0.015 respectively).  Some cases did not require pre-
operative administration of doxazosin; these were 
included in Group 2.  According to the preoperative 
biochemical data,  urinary metanephrine and urinary 
normetanephrine levels were significantly correlated 
with postoperative catecholamine support (0.54 vs 
0.09 mg/day,  p = 0.008; 1.94 vs 0.50 mg/day,  p = 0.018 
respectively).
Clinical variables significantly associated with pro-
longed hypotension requiring postoperative catechol-
amine support included larger tumor size,  blood pres-
sure fluctuation,  higher urinary metanephrine and 
higher urinary normetanephrine levels.  When opti-
mum cutoffs for continuous variables were selected 
using the area under the curve (AUC) derived from the 
receiver operating characteristic curve,  the following 3 
preoperative dichotomous variables were selected as 
predictors: tumor size > 34.5 mm (AUC = 0.75),  uri-
nary metanephrine > 0.205 mg/day (AUC = 0.837),  uri-
nary normetanephrine > 0.665 mg/day (AUC = 0.816) 
(Fig. 1).  In univariate logistic analysis,  these factors 
were significant predictors of prolonged hypotension 
requiring postoperative catecholamine support (Table 
2).
Discussion
The aim of this study was to identify preoperative 
predictors of cases with persistent hypotension after 
adrenalectomy for pheochromocytoma.  Other studies 
have reported frequencies of hypotension after adrenal-
ectomy for pheochromocytoma was about 50% [1 , 5].  
In this study,  44.8% of patients needed catecholamine 
supplementation after surgery,  which was not signifi-
cantly different from other reports.  According to our 
study,  there were three predictors of persistent postop-
erative hypotension.  Tumor size,  urinary metaneph-
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rine,  and urinary normetanephrine were significantly 
correlated with postoperative catecholamine support.  
Previous reports have cited blood circulation volume,  
operation time,  and the intraoperative catecholamine 
index as predictors of postoperative hypotension [1-4].  
However,  catecholamines originating elsewhere than 
the pheochromocytoma also affects blood pressure 
during surgery; some reports therefore state that pre-
diction of fluctuations in blood pressure is difficult 
[6-8].
Tumor size has been noted as a predictor of signifi-
cant blood pressure fluctuations in other reports 
[1 , 4 , 6 , 7 , 9].  It is suggested that catecholamine outflow 
due to compression of the tumor may increase with size 
because large tumors have many collateral vessels and 
the tumor is manipulated for a long time [4 , 6 , 7 , 9].
As biochemical factors,  urinary metanephrine and 
urinary normetanephrine showed significant differences 
between the 2 groups.  Various studies on biochemical 
factors have been reported so far.  Serum adrenaline,  
urinary noradrenaline,  and urinary VMA are also 
regarded as predictors of intraoperative blood pressure 
fluctuations [1-4].  Metanephrine and normetanephrine 
are metabolites of adrenaline and noradrenaline,  
respectively,  and VMA is the final metabolite of both.  
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Table 1　 Comparison of characteristics in patients who needed catecholamine support after surgery and those who did not
Needed catecholamine
support after surgery, 
n=13
Did not need catecholamine 
support after surgery, 
n=16
P value
Age,  median,  years old 68 (33-76) 53 (20-73) .045
Gender,  male/female (number) 8/5 7/9 .339
BMI,  median,  kg/m2 21.4 (15.8-26.8) 22.7 (16.0-27.7) .531
Tumor size,  median,  mm diameter 50 (30-90) 32 (16-150) .022
Tumor side,  right/left/bilateral (number) 4/9/0 4/11/1 .528
Approach,  laparoscopic/laparotomy/thoracoabdominal 10/3/0 13/2/1 .381
Surgical time,  median,  min 201 (135-565) 293 (115-410) .232
Blood loss,  median mL 10 (10-2,190) 70 (10-900) .589
Postoperative hospitalization,  days blood pressure 
fluctuation,  median,  mmHg 8 (7-16) 8.5 (4-15) .722
(Subtract minimum sBP after tumor resection from 
maximum sBP before tumor resection) 110 (43-230) 71 (16-152) .015
Preoperative cumulative dose of doxazosin,  median,  mg 216 (64-590) 60.5 (0-1,440) .110
Duration of catecholamine need,  median,  hours 20 (1-94)
Serum adrenaline,  median,  pg/mL 0.08 (0.02-3.18) 0.06 (0.02-2.04) .525
Serum noradrenaline,  median,  pg/mL 1.43 (0.23-17.77) 1.11 (0.21-11.60) .905
Serum dopamine,  median,  pg/mL 0.035 (0.02-0.29) 0.05 (0.02-0.09) .536
Urinary adrenaline,  median,  μg/day 13.4 (8.0-215.4) 28.6 (1.5-456.8) .847
Urinary noradrenaline,  median,  μg/day 270.9 (101-4,240) 433.9 (53.4-2,132.1) .898
Urinary dopamine,  median,  μg/day 840 (435.9-9,018,9) 496.6 (39-1,963) .088
Urinary VMA,  median,  mg/day 7.60 (0.77-18.73) 4.08 (0.38-10.32) .252
Urinary metanephrine,  median,  mg/day 0.54 (0.10-17.14) 0.09 (0.02-2.10) .008
Urinary normetanephrine,  median,  mg/day 1.94 (0.65-8.59) 0.50 (0.06-63.7) .018
Changes between pre- and post operative levels of urinary 
metanephrine,  median,  mg/day −0.23 (−14.51-−0.02) −0.45 (−2.08-+0.01) .069
Changes between pre- and post operative levels of urinary 
noremtanephrine,  median,  mg/day −1.42 (−8.42-−0.52) −0.325 (−63.4-−0.02) .069




Odds 95%CI P value
Tumor size >34.5 mm 4.29 0.84-21.8 0.079
Preoperative urinary
metanephrine >0.205 6.67 1.15-38.8 0.035
Preoperative urinary
normetanephrine >0.665 17.6 1.71-181.3 0.016
Adrenaline and noradrenaline have several minutes of 
half-life and depend largely on the patient’s diet and 
exercise.  Similarly,  urinary VMA tends to be affected 
by diet and medicine.  Therefore,  measurements of 
these factors are not constant over time,  and one-time 
measurements sometimes show false negatives.
By contrast,  urinary metanephrine and urinary 
normetanephrine are highly stable,  and there have been 
cases diagnosed as pheochromocytoma because of the 
high urinary levels of metanephrine and normetaneph-
rine even if urinary catecholamines are in the normal 
range.  From these facts,  it was agreed that urinary 
metanephrine and urinary normetanephrine are useful 
for the diagnosis of pheochromocytoma,  but their util-
ity as a predictive factor for postoperative hypotension 
is divided.  Namekawa et al.  showed that urinary 
normetanephrine could be a predictor of postoperative 
hypotension in univariate analysis [1].  Furthermore,  
their multivariate analysis showed that intraoperative 
catecholamine index and surgery time were signifi-
cantly related to postoperative hypotension,  and they 
reported that urinary normetanephrine strongly cor-
related to both [1].  In our study,  urinary metanephrine 
and urinary normetanephrine were significantly cor-
related with postoperative hypotension in univariate 
logistic analysis.  Age also showed significant differences 
between the 2 groups,  but we did not consider it as a 
good predictor.  As ageing,  calcification occurs in the 
vascular wall,  and vascular compliance decreases.  
Therefore,  elderly people both with and without pheo-
chromocytoma may have greater perioperative blood 
pressure fluctuations.  Thus we decided to exclude age as 
a candidate predictor.
There are a few limitations to this study.  The num-
ber of cases was small and it was a retrospective exam-
ination.  Details of perioperative management,  such as 
anesthesia method and administration of antihyperten-
sive medication other than doxazosin,  for example 
ARBs and Ca blockers,  were not constant across all 
subjects.  Only very recently did laboratory tests for 
plasma free metanephrine fractions become covered by 
Japanese insurance.  In future studies,  it will be possible 
to use the data of plasma free metanephrine fraction,  
and thus another factors may be identified as a reliable 
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Fig. 1　 Receiver operating characteristic curve of each continuous variable 
as a candidate predictor.  The three predictive variables were (A) tumor size 
>34.5 mm,  (B) preoperative urine metanephrine >0.205 ug/day,  and (C) pre-
operative urine normetanephrine >0.665 ug/day.  Each value was chosen to 
have the maximum sensitivity combined with the minimal loss of specificity.
predictor of postoperative hypotension.
In conclusions,  tumor size,  urinary metanephrine 
and urinary normetanephrine levels were especially 
correlated with postoperative hypotension.  These pre-
dictors may help in the safe perioperative management 
of pheochromocytoma patients treated with adrenalec-
tomy.  Further research with a greater number of cases 
and more purposeful study design,  i.e.,  a prospective 
study designed to maintain a constant dose of preoper-
ative doxazosin and more explicit criteria for starting 
and stopping postoperative catecholamines,  may yield 
more conclusive results.
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